![68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy | Scientific Reports 68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-24688-3/MediaObjects/41598_2022_24688_Fig1_HTML.jpg)
68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy | Scientific Reports
![Diagnostics | Free Full-Text | PSMA Receptor-Based PET-CT: The Basics and Current Status in Clinical and Research Applications Diagnostics | Free Full-Text | PSMA Receptor-Based PET-CT: The Basics and Current Status in Clinical and Research Applications](https://www.mdpi.com/diagnostics/diagnostics-13-00158/article_deploy/html/images/diagnostics-13-00158-g001.png)
Diagnostics | Free Full-Text | PSMA Receptor-Based PET-CT: The Basics and Current Status in Clinical and Research Applications
![68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients' disease management and adequacy of impact | Scientific Reports 68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients' disease management and adequacy of impact | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-58975-8/MediaObjects/41598_2020_58975_Fig1_HTML.png)
68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients' disease management and adequacy of impact | Scientific Reports
![La técnica PET-TAC con Flúor-PSMA triplica la sensibilidad a la hora de detectar recaídas de cáncer de próstata - Farmacosalud La técnica PET-TAC con Flúor-PSMA triplica la sensibilidad a la hora de detectar recaídas de cáncer de próstata - Farmacosalud](https://farmacosalud.com/wp-content/uploads/2020/07/222-Caso-Cl%C3%ADnico-PET-TAC-18-FPSMA.jpg)
La técnica PET-TAC con Flúor-PSMA triplica la sensibilidad a la hora de detectar recaídas de cáncer de próstata - Farmacosalud
![FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer | Imaging Technology News FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer | Imaging Technology News](http://www.itnonline.com/sites/default/files/PSMA_PET.jpg)
FDA Approves First Commercially Available PSMA PET Imaging Agent for Prostate Cancer | Imaging Technology News
![The Role of PSMA PET/CT and PET/MRI in the Initial Staging of Prostate Cancer - European Urology Focus The Role of PSMA PET/CT and PET/MRI in the Initial Staging of Prostate Cancer - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/asset/3886fb6a-61c3-4cb5-accd-10b5fa39dc5c/gr1.jpg)
The Role of PSMA PET/CT and PET/MRI in the Initial Staging of Prostate Cancer - European Urology Focus
![NEW CRP: Use of PET–CT with Gallium-68 Labelled Prostate Specific Membrane Antigen (PSMA) in the Diagnosis and Follow-up of Patients with Prostate Cancer (E13046) | IAEA NEW CRP: Use of PET–CT with Gallium-68 Labelled Prostate Specific Membrane Antigen (PSMA) in the Diagnosis and Follow-up of Patients with Prostate Cancer (E13046) | IAEA](https://www.iaea.org/sites/default/files/crp-prostate1140x640.jpg)
NEW CRP: Use of PET–CT with Gallium-68 Labelled Prostate Specific Membrane Antigen (PSMA) in the Diagnosis and Follow-up of Patients with Prostate Cancer (E13046) | IAEA
LA INTELIGENCIA ARTIFICIAL EN EL ALGORITMO DIAGNOSTICO DEL PET-CT 18F-PSMA EN LA RECIDIVA BIOQUIMICA DEL CANCER DE PROSTATA. CRI
![PET-TAC con 18F-PSMA, prueba diagnóstica que permite la detección precoz de recaídas en el cáncer de próstata | Las Provincias PET-TAC con 18F-PSMA, prueba diagnóstica que permite la detección precoz de recaídas en el cáncer de próstata | Las Provincias](https://s1.ppllstatics.com/lasprovincias/www/multimedia/202010/12/media/cortadas/4-kXIH-U120385457726ZV-624x832@Las%20Provincias.jpg)
PET-TAC con 18F-PSMA, prueba diagnóstica que permite la detección precoz de recaídas en el cáncer de próstata | Las Provincias
Quirónsalud Madrid incorpora el PET-TAC con PSMA, la mejor herramienta diagnóstica de detección de recaídas del cáncer de próstata | Quirónsalud
![PET/TC con 68Ga-PSMA, importancia en la práctica hospitalaria. Visión del oncólogo radioterápico - ScienceDirect PET/TC con 68Ga-PSMA, importancia en la práctica hospitalaria. Visión del oncólogo radioterápico - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2253654X18301501-gr1.jpg)
PET/TC con 68Ga-PSMA, importancia en la práctica hospitalaria. Visión del oncólogo radioterápico - ScienceDirect
![SciELO - Brasil - Impact of <sup>68</sup>GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter study Impact of <sup>68</sup>GA-PSMA PET / CT SciELO - Brasil - Impact of <sup>68</sup>GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter study Impact of <sup>68</sup>GA-PSMA PET / CT](https://minio.scielo.br/documentstore/1677-6119/qpZZZW5nFmHVkyXd6K7hctp/b3e13c0edc362abe0f6389f8ff2227391155302b.jpg)